NewLink Genetics' Incubator/Accelerator Round

NewLink Genetics raised a round of funding on , . Investors include Iowa State University Research Park.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.…

Articles about NewLink Genetics' Incubator/Accelerator Round: